Rigel Pharmaceuticals Inc. logo

Rigel Pharmaceuticals Inc.

RIGL | NASDAQ
Chart Builder DCF Calculator
$47.92
+$0.83 (+1.76%)
Sep 22, 2026, 11:21 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
40.58M 56.75M 32.79M 24.46M 18.89M 30.37M
Short-Term Investments
114.38M 20.58M 24.15M 33.75M 106.08M 26.95M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
1.91M 1.44M 3.06M 640K 974K 824K
Receivables
51.76M 41.62M 30.55M 40.32M 15.47M 15.97M
Inventory
11.51M 6M 5.52M 9.12M 6.62M 1.64M
Other Current Assets
21.94M 10.17M 6.26M 8.26M n/a n/a
Total Current Assets
240.17M 135.1M 99.27M 115.9M 154.47M 88.98M
Property-Plant & Equipment
920K 338K 1.03M 2.79M 11.89M 20.57M
Goodwill & Intangibles
24.75M 27.1M 13.88M 14.95M n/a n/a
Total Long-Term Assets
273.43M 28.87M 17.96M 18.38M 12.86M 21.4M
Total Assets
513.59M 163.98M 117.23M 134.28M 167.33M 110.38M
Account Payables
7.19M 3.34M 7.14M 22.51M 3.8M 3.71M
Deferred Revenue
1.36M 27.8M 17.04M 13.51M 10.51M 3.02M
Short-Term Debt
30.43M 7.27M 7.23M n/a n/a n/a
Other Current Liabilities
48.35M 10.14M 12.32M 13.86M 24.2M 9.59M
Total Current Liabilities
99.24M 63.3M 53.27M 65.21M 63.55M 40.84M
Long-Term Debt
22.48M 52.41M 52.37M 39.45M 19.91M 19.82M
Other Long-Term Liabilities
n/a 44.98M 39.94M 42.26M 52.73M 5.05M
Total Long-Term Liabilities
22.88M 97.39M 92.6M 82.68M 73.4M 35.51M
Total Liabilities
122.11M 160.69M 145.87M 147.9M 136.95M 76.35M
Total Debt
53.3M 59.97M 60.58M 41.55M 30.57M 39.09M
Book Value
391.48M 3.29M -28.64M -13.62M 30.37M 34.03M
Book Value Per Share
20.78 0.19 -1.65 -0.79 1.78 2.02
Common Stock
18K 18K 17K 174K 172K 169K
Retained Earnings
-1.02B -1.39B -1.41B -1.38B -1.32B -1.31B
Comprehensive Income
181K 10K 8K -153K -102K -4K
Shareholders Equity
391.48M 3.29M -28.64M -13.62M 30.37M 34.03M
Total Investments
114.38M 20.58M 24.15M 33.75M 106.08M 26.95M

© 2026 bestshares.com. All rights reserved.